Open original FDA record ↗Recall record
- FDA identifier
- Z-0753-2024
- Company in FDA record
- Randox Laboratories Ltd.
- FDA classification date
- Jan 18, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Target for Alkaline Phosphatase (ALP) for the AMP optimized to IFCC 37C method has been mis-assigned for the RX Series instruments by approximately 10% on Quality Control and patient samples
Source facts
- Action
- Randox issued Urgent Medical Device Correction letter on 11/20/23 to the distribution center within the USA. The US distributor contacted the customer direct via email. Letter states reason for recall, health risk and action to take: Review your calibrator inventory of this lot and assess your laboratories needs for reimbursement for discarded inventory. " Discuss the contents of this notice with your Medical Director. " Complete and return the response form, 12187-QA to technical.services@randox.com within five working days. If you have any questions or concerns please contact Randox Technical Services.
- Initiated
- 2023-11-20
- Root cause
- Under Investigation by firm
- Distribution
- US Nationwide including Puerto Rico.
- Recall number
- Z-0753-2024
- Recall status
- Open, Classified
- CDRH record ID
- 204990
- FDA classified
- 2024-01-18
- Recall event number
- 93630